Curcumin is widely used to impart color and flavor to food, but scientists have discovered that this yellow powder derived from the roots of the turmeric plant (Curcuma longa) can also help prevent or combat stomach cancer.
The study by researchers at the Federal University of São Paulo (UNIFESP) and the Federal University of Pará (UFPA) in Brazil identified possible therapeutic effects of this pigment and of other bioactive compounds found in food on stomach cancer, the third and fifth most frequent type of cancer among Brazilian men and women, respectively.
The study was part of a Thematic Project supported by FAPESP. Its findings have been published in the journal Epigenomics.
“We undertook a vast review of the scientific literature on all nutrients and bioactive compounds with the potential to prevent or treat stomach cancer and found that curcumin is one of them,” Danielle Queiroz Calcagno, a professor at UFPA and first author of the study, told Agência FAPESP.
According to Calcagno, who conducted postdoctoral research at UNIFESP with a scholarship from FAPESP, compounds such as cholecalciferol (a form of vitamin D), resveratrol (a polyphenol) and quercetin can prevent or combat stomach cancer because they are natural regulators of histone activity.
Histones are proteins in cell nuclei that organize the DNA double helix into structural units called nucleosomes. Each nucleosome is made of DNA coiled like a spool around eight histone proteins (a histone octamer) to compact the DNA so that it fits in the cell, where it is packaged into chromatin.
Posttranslational chemical modification of the amino acid chain in these proteins, such as acetylation (introduction of an acetyl group) or methylation (addition of a methyl group), can affect chromatin compaction and hence gene expression.
“If the histones are acetylated, for example, the chromatin will be less condensed, and a gene in a region of the DNA segment inside it will be available to be expressed. In contrast, if the histones aren’t acetylated, the chromatin will be more condensed, and the gene won’t be expressed,” Calgano explained.
Research conducted in recent years has suggested that posttranslational histone modification causes alterations in gene expression without affecting the DNA sequence. These epigenetic variations influence the development of different types of cancer.
To determine whether this hypothesis also applied to stomach cancer, several groups of researchers coordinated by Marília de Arruda Cardoso Smith, a professor at UNIFESP, studied histone acetylation patterns in stomach cell samples from healthy individuals and patients diagnosed with stomach cancer.
The researchers found that the cells from stomach cancer patients displayed alterations in the pattern of expression of histone acetyltransferases (HATs) and histone deacetylases (HDACs). These alterations are epigenetic and affect the structure and integrity of the genome in many tumors, including stomach cancer.
A review article authored by Brazilian researchers evaluated several compounds with therapeutic potential against gastric tumors
Because recent research has also shown that nutrients and bioactive compounds can regulate the activity of HATs and HDACs, the scientists at UNIFESP and UFPA set out to identify any that might influence histone acetylation and hence help prevent stomach cancer or even treat the disease.
In addition to curcumin, other compounds found to play a key role in modulating histone activity were cholecalciferol, resveratrol (present mainly in grape seeds and red wine), quercetin (abundant in apples, broccoli and onions), garcinol (isolated from the bark of the kokum tree, Garcinia indica), and sodium butyrate (produced by gut bacteria via fermentation of dietary fiber).
“These compounds can favor the activation or repression of genes involved in the development of stomach cancer by promoting or inhibiting histone acetylation,” Calcagno said.
Curcumin, for example, influences histone modifications primarily by inhibiting HATs and HDACs to suppress cancer cell proliferation and induce apoptosis (programmed cell death). Garcinol, whose chemical structure resembles that of curcumin, inhibits HATs and helps prevent stomach cancer by neutralizing free radicals.
“We now plan to clarify the anticancer and epigenetic effects of bioactive compounds derived from plants in the Amazon, such as açaí [Euterpe oleracea] and nanche or hogberry [Byrsonima crassifolia], with a view to their future use in the prevention and treatment of stomach cancer,” Calcagno said.
The Epigenomics article “Role of histone acetylation in gastric cancer: implications of dietetic compounds and clinical perspectives” (DOI: 10.2217/epi-2018-0081) by Danielle Q. Calcagno, Fernanda Wisnieski, Elizangela R. da Silva Mota, Stefanie B. Maia de Sousa, Jéssica M. Costa da Silva, Mariana F. Leal, Carolina O. Gigek, Leonardo C. Santos, Lucas T. Rasmussen, Paulo P. Assumpção, Rommel R. Burbano and Marília A. C. Smith can be retrieved from www.futuremedicine.com/doi/abs/10.2217/epi-2018-0081.
This text was originally published by FAPESP Agency according to Creative Commons license CC-BY-NC-ND. Read the original here.
Contacts and sources:
Elton AlissonFundação de Amparo à Pesquisa do Estado de São Paulo
Citation: Role of histone acetylation in gastric cancer: implications of dietetic compounds and clinical perspectives
Danielle Q Calcagno, Fernanda Wisnieski, Elizangela R da Silva Mota, Stefanie B Maia de Sousa, Jéssica M Costa da Silva, Mariana F Leal, Carolina O Gigek, Leonardo C Santos, Lucas T Rasmussen, Paulo P Assumpção, Rommel R Burbano, Marília AC Smith. . Epigenomics, 2019; 11 (3): 349 DOI: 10.2217/epi-2018-0081